Zenosense, Inc. (ZENO) Developing Game Changing Medical Nano-Magnetic Diagnostic Technology
Global Point Of Care (POC) diagnostics market projected to grow from $23.71 billion in 2017 to $38.13 billion in 2022 Patented diagnostic technology for POC devices Initial development of MIDS Cardiac™, a POC device for early and rapid cardiac biomarker detection Global cardiac biomarkers market expected to reach $13.3 billion by 2024 Delivering MIDS Cardiac™ would allow the technology to be applied to multiple other immunoassay tests with a global market that’s projected to be worth $25.45 billion by 2021 The global point-of-care (POC) diagnostics market is forecast to grow at a CAGR of 10 percent, from $23.71 billion in…